Therefore, we investigated whether its expression and/or activity are also altered in patients with chronic obstructive pulmonary disease (COPD) and other obstructive respiratory diseases like asthma and which disease-specific conditions can change TRAP expression/activity. Here, ACP5 is linked to asthma.